DEF 14AELTXCIK 0001601485

Elicio Therapeutics, Inc.

Name: SEC EDGAR filing 0001601485-26-000061
Creator: Elicio Therapeutics, Inc.
License: https://www.usa.gov/government-works

Proxy statement (DEF 14A) filed October 9, 2026.

Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.

Open the filing on SEC.gov

New to the DEF 14A? What it is and how to read one

Filing facts

Accession number: 0001601485-26-000061
Filer: Elicio Therapeutics, Inc.
Ticker: ELTX
CIK: 0001601485
Form type: DEF 14A
Form description: Proxy statement
Filed at: October 9, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: October 9, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Elicio Therapeutics, Inc.

See all 42 filings from Elicio Therapeutics, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1601485/000160148526000061/0001601485-26-000061-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Elicio Therapeutics, Inc. (0001601485) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001601485-26-000061.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.